HSG4112
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for HSG4112, covering 2024-03-19 to 2024-03-19. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of HSG4112 in Overweight and Obese Patients [Phase 2]